 Wendy Tzou
Concepts (311)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 68 | 2023 | 291 | 15.130 |
Why?
| | Tachycardia, Ventricular | 43 | 2023 | 153 | 11.990 |
Why?
| | Atrial Fibrillation | 19 | 2023 | 324 | 5.330 |
Why?
| | Cardiomyopathies | 17 | 2022 | 298 | 3.940 |
Why?
| | Arrhythmias, Cardiac | 22 | 2023 | 278 | 3.060 |
Why?
| | Cicatrix | 6 | 2022 | 50 | 2.330 |
Why?
| | Electrophysiologic Techniques, Cardiac | 16 | 2022 | 70 | 2.320 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2023 | 152 | 2.160 |
Why?
| | Defibrillators, Implantable | 15 | 2023 | 286 | 1.800 |
Why?
| | Electrocardiography | 18 | 2023 | 562 | 1.770 |
Why?
| | Heart Diseases | 6 | 2023 | 330 | 1.710 |
Why?
| | Pacemaker, Artificial | 5 | 2023 | 107 | 1.620 |
Why?
| | Ventricular Premature Complexes | 6 | 2022 | 26 | 1.550 |
Why?
| | Heart Ventricles | 11 | 2022 | 708 | 1.520 |
Why?
| | Pericardium | 9 | 2021 | 49 | 1.470 |
Why?
| | Atrioventricular Block | 2 | 2021 | 37 | 1.380 |
Why?
| | Amiodarone | 2 | 2021 | 23 | 1.320 |
Why?
| | Pulmonary Veins | 3 | 2019 | 81 | 1.290 |
Why?
| | Cardiac Pacing, Artificial | 5 | 2023 | 79 | 1.280 |
Why?
| | Aortic Valve Stenosis | 4 | 2023 | 272 | 1.280 |
Why?
| | Heart Failure | 6 | 2023 | 1952 | 1.110 |
Why?
| | Atrial Appendage | 3 | 2022 | 10 | 1.080 |
Why?
| | Heart Conduction System | 10 | 2023 | 82 | 1.050 |
Why?
| | Myocardium | 12 | 2023 | 908 | 1.020 |
Why?
| | Treatment Outcome | 35 | 2023 | 9089 | 0.950 |
Why?
| | Cardiac Electrophysiology | 6 | 2021 | 12 | 0.950 |
Why?
| | Echocardiography | 6 | 2021 | 554 | 0.930 |
Why?
| | Death, Sudden, Cardiac | 5 | 2023 | 160 | 0.910 |
Why?
| | Electric Countershock | 6 | 2023 | 104 | 0.910 |
Why?
| | Humans | 105 | 2023 | 114709 | 0.910 |
Why?
| | Muscular Dystrophies | 1 | 2023 | 36 | 0.870 |
Why?
| | Recurrence | 15 | 2022 | 936 | 0.860 |
Why?
| | Electrocardiography, Ambulatory | 3 | 2019 | 54 | 0.850 |
Why?
| | Endocardium | 7 | 2022 | 30 | 0.840 |
Why?
| | Electrodes | 6 | 2022 | 100 | 0.810 |
Why?
| | Myocarditis | 1 | 2023 | 93 | 0.800 |
Why?
| | Postoperative Complications | 7 | 2019 | 2127 | 0.780 |
Why?
| | Pericardial Effusion | 2 | 2022 | 21 | 0.780 |
Why?
| | Carotid Arteries | 4 | 2006 | 180 | 0.770 |
Why?
| | Surgery, Computer-Assisted | 1 | 2021 | 62 | 0.710 |
Why?
| | Neuromuscular Diseases | 1 | 2021 | 89 | 0.710 |
Why?
| | Esophagus | 3 | 2023 | 226 | 0.700 |
Why?
| | Cardiology | 5 | 2020 | 259 | 0.680 |
Why?
| | Ablation Techniques | 2 | 2019 | 29 | 0.680 |
Why?
| | Anti-Arrhythmia Agents | 8 | 2023 | 106 | 0.670 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2022 | 346 | 0.660 |
Why?
| | Heart Atria | 5 | 2023 | 108 | 0.660 |
Why?
| | Consensus | 9 | 2020 | 535 | 0.630 |
Why?
| | Tunica Intima | 4 | 2008 | 78 | 0.610 |
Why?
| | Heart Rate | 6 | 2019 | 704 | 0.600 |
Why?
| | Action Potentials | 7 | 2019 | 406 | 0.570 |
Why?
| | Heart Block | 3 | 2023 | 38 | 0.560 |
Why?
| | Epicardial Mapping | 5 | 2022 | 5 | 0.540 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2017 | 42 | 0.530 |
Why?
| | Risk Factors | 17 | 2023 | 8625 | 0.530 |
Why?
| | Aged | 33 | 2023 | 19078 | 0.520 |
Why?
| | Therapeutic Irrigation | 4 | 2020 | 67 | 0.520 |
Why?
| | Cardiac Catheters | 4 | 2020 | 15 | 0.510 |
Why?
| | Venous Thrombosis | 1 | 2017 | 140 | 0.500 |
Why?
| | Middle Aged | 40 | 2020 | 26747 | 0.500 |
Why?
| | Arthritis, Rheumatoid | 1 | 2023 | 1001 | 0.490 |
Why?
| | Body Temperature | 3 | 2015 | 208 | 0.470 |
Why?
| | Risk Assessment | 13 | 2020 | 2973 | 0.470 |
Why?
| | Catheters | 4 | 2022 | 63 | 0.470 |
Why?
| | Multimodal Imaging | 3 | 2019 | 88 | 0.460 |
Why?
| | Societies, Medical | 5 | 2020 | 663 | 0.450 |
Why?
| | Bundle-Branch Block | 3 | 2023 | 29 | 0.440 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2013 | 15 | 0.440 |
Why?
| | Male | 49 | 2021 | 55554 | 0.430 |
Why?
| | Aortic Valve | 4 | 2023 | 400 | 0.400 |
Why?
| | Time Factors | 12 | 2021 | 6122 | 0.400 |
Why?
| | Heart | 6 | 2022 | 609 | 0.400 |
Why?
| | Predictive Value of Tests | 8 | 2019 | 1795 | 0.400 |
Why?
| | Female | 47 | 2023 | 59483 | 0.390 |
Why?
| | Swine | 7 | 2023 | 700 | 0.390 |
Why?
| | Cattle | 12 | 2020 | 921 | 0.350 |
Why?
| | Retrospective Studies | 23 | 2023 | 12511 | 0.350 |
Why?
| | Carotid Artery Diseases | 2 | 2008 | 57 | 0.340 |
Why?
| | Tunica Media | 3 | 2008 | 35 | 0.340 |
Why?
| | Atrioventricular Node | 1 | 2009 | 14 | 0.340 |
Why?
| | Incidence | 6 | 2021 | 2312 | 0.340 |
Why?
| | Ultrasonography | 3 | 2008 | 629 | 0.330 |
Why?
| | Ventricular Function, Left | 5 | 2021 | 467 | 0.330 |
Why?
| | Cardiac Catheterization | 2 | 2022 | 534 | 0.330 |
Why?
| | Tachycardia, Supraventricular | 1 | 2009 | 42 | 0.330 |
Why?
| | Cardiac Surgical Procedures | 3 | 2021 | 413 | 0.320 |
Why?
| | Stroke Volume | 8 | 2021 | 508 | 0.320 |
Why?
| | Survival Rate | 5 | 2019 | 1642 | 0.300 |
Why?
| | Decision Support Techniques | 2 | 2022 | 351 | 0.300 |
Why?
| | Reoperation | 3 | 2019 | 514 | 0.290 |
Why?
| | Body Surface Potential Mapping | 5 | 2019 | 7 | 0.280 |
Why?
| | Hypercapnia | 1 | 2007 | 51 | 0.280 |
Why?
| | Follow-Up Studies | 12 | 2021 | 4420 | 0.280 |
Why?
| | Genetic Testing | 1 | 2009 | 379 | 0.280 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2018 | 359 | 0.280 |
Why?
| | Coronary Circulation | 1 | 2007 | 133 | 0.270 |
Why?
| | Sarcoidosis | 2 | 2019 | 135 | 0.270 |
Why?
| | Cardiac Imaging Techniques | 2 | 2019 | 21 | 0.260 |
Why?
| | Adult | 23 | 2021 | 30542 | 0.250 |
Why?
| | Hot Temperature | 3 | 2023 | 304 | 0.250 |
Why?
| | Arteriosclerosis | 1 | 2005 | 82 | 0.250 |
Why?
| | Blood Flow Velocity | 1 | 2007 | 387 | 0.250 |
Why?
| | Coronary Vessels | 1 | 2007 | 227 | 0.250 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 136 | 0.250 |
Why?
| | Bundle of His | 2 | 2023 | 16 | 0.240 |
Why?
| | Reproducibility of Results | 6 | 2019 | 2762 | 0.240 |
Why?
| | Accessory Atrioventricular Bundle | 2 | 2021 | 11 | 0.230 |
Why?
| | Liposomes | 2 | 2023 | 146 | 0.230 |
Why?
| | Cholesterol | 1 | 2005 | 368 | 0.230 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2020 | 1214 | 0.220 |
Why?
| | Animals | 17 | 2023 | 31761 | 0.210 |
Why?
| | Biophysical Phenomena | 2 | 2020 | 63 | 0.210 |
Why?
| | Temperature | 2 | 2023 | 575 | 0.210 |
Why?
| | Registries | 3 | 2022 | 1758 | 0.210 |
Why?
| | Thromboembolism | 1 | 2023 | 93 | 0.200 |
Why?
| | Metabolic Syndrome | 1 | 2005 | 323 | 0.200 |
Why?
| | Prospective Studies | 6 | 2023 | 6215 | 0.200 |
Why?
| | Philadelphia | 3 | 2019 | 46 | 0.190 |
Why?
| | Pre-Excitation Syndromes | 1 | 2021 | 4 | 0.190 |
Why?
| | Skin | 1 | 2005 | 659 | 0.190 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 2 | 2012 | 35 | 0.190 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2021 | 22 | 0.190 |
Why?
| | Coronary Sinus | 1 | 2020 | 7 | 0.180 |
Why?
| | Prevalence | 5 | 2021 | 2249 | 0.180 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 1 | 2020 | 28 | 0.180 |
Why?
| | Anticoagulants | 3 | 2023 | 547 | 0.180 |
Why?
| | Prognosis | 7 | 2019 | 3334 | 0.170 |
Why?
| | Heart-Assist Devices | 2 | 2023 | 485 | 0.170 |
Why?
| | Papillary Muscles | 1 | 2019 | 14 | 0.170 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2019 | 19 | 0.170 |
Why?
| | Patient Safety | 2 | 2020 | 278 | 0.170 |
Why?
| | Colorado | 3 | 2019 | 4085 | 0.170 |
Why?
| | Hypertension | 2 | 2017 | 1059 | 0.160 |
Why?
| | Aortic Valve Insufficiency | 1 | 2019 | 45 | 0.160 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 249 | 0.160 |
Why?
| | Esophageal Fistula | 1 | 2019 | 17 | 0.160 |
Why?
| | Mitral Valve Insufficiency | 1 | 2019 | 63 | 0.160 |
Why?
| | Kaplan-Meier Estimate | 4 | 2018 | 815 | 0.160 |
Why?
| | In Vitro Techniques | 5 | 2020 | 1013 | 0.160 |
Why?
| | Heparin | 1 | 2020 | 222 | 0.160 |
Why?
| | Fibrosis | 2 | 2018 | 453 | 0.150 |
Why?
| | Medicare | 3 | 2022 | 665 | 0.150 |
Why?
| | United States | 9 | 2022 | 12175 | 0.150 |
Why?
| | Ventricular Function, Right | 1 | 2019 | 251 | 0.140 |
Why?
| | Antihypertensive Agents | 2 | 2017 | 429 | 0.140 |
Why?
| | Materials Testing | 2 | 2016 | 337 | 0.140 |
Why?
| | Environment | 1 | 2018 | 336 | 0.140 |
Why?
| | Echocardiography, Transesophageal | 1 | 2017 | 89 | 0.130 |
Why?
| | Magnets | 1 | 2016 | 15 | 0.130 |
Why?
| | Disease Management | 1 | 2020 | 560 | 0.130 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 121 | 0.130 |
Why?
| | Adipose Tissue | 1 | 2020 | 539 | 0.130 |
Why?
| | Ferric Compounds | 1 | 2016 | 40 | 0.130 |
Why?
| | Heart Injuries | 1 | 2016 | 36 | 0.130 |
Why?
| | Equipment Design | 4 | 2020 | 508 | 0.130 |
Why?
| | Mitral Valve | 2 | 2019 | 87 | 0.130 |
Why?
| | Thermography | 1 | 2015 | 11 | 0.130 |
Why?
| | Adiposity | 1 | 2020 | 457 | 0.120 |
Why?
| | Metal Nanoparticles | 1 | 2016 | 75 | 0.120 |
Why?
| | Blood Coagulation | 1 | 2017 | 217 | 0.120 |
Why?
| | Odds Ratio | 2 | 2010 | 954 | 0.120 |
Why?
| | Heart Transplantation | 1 | 2020 | 667 | 0.120 |
Why?
| | Feasibility Studies | 2 | 2015 | 737 | 0.120 |
Why?
| | Medical Records | 1 | 2015 | 153 | 0.120 |
Why?
| | Stroke | 1 | 2022 | 1019 | 0.120 |
Why?
| | Nanotubes, Carbon | 1 | 2014 | 43 | 0.120 |
Why?
| | Fee-for-Service Plans | 1 | 2014 | 83 | 0.110 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 29 | 0.110 |
Why?
| | Artificial Intelligence | 3 | 2023 | 145 | 0.110 |
Why?
| | Energy Transfer | 1 | 2013 | 47 | 0.110 |
Why?
| | Systole | 2 | 2019 | 171 | 0.110 |
Why?
| | Hemodynamics | 1 | 2017 | 1013 | 0.110 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 664 | 0.100 |
Why?
| | Primary Prevention | 1 | 2014 | 172 | 0.100 |
Why?
| | Cohort Studies | 5 | 2021 | 4899 | 0.100 |
Why?
| | Ventricular Fibrillation | 1 | 2012 | 51 | 0.100 |
Why?
| | Sinus of Valsalva | 1 | 2012 | 11 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 3 | 2018 | 3031 | 0.090 |
Why?
| | Heart Septum | 1 | 2011 | 26 | 0.090 |
Why?
| | Myocardial Ischemia | 1 | 2012 | 234 | 0.090 |
Why?
| | Atrial Flutter | 1 | 2011 | 25 | 0.090 |
Why?
| | Nanoparticles | 1 | 2014 | 313 | 0.090 |
Why?
| | Asia | 2 | 2020 | 53 | 0.090 |
Why?
| | Latin America | 2 | 2020 | 69 | 0.090 |
Why?
| | Pressure | 1 | 2011 | 218 | 0.090 |
Why?
| | Pennsylvania | 1 | 2010 | 94 | 0.090 |
Why?
| | Telemetry | 1 | 2010 | 36 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2268 | 0.080 |
Why?
| | Brugada Syndrome | 1 | 2009 | 9 | 0.080 |
Why?
| | Genetic Diseases, Inborn | 1 | 2009 | 36 | 0.080 |
Why?
| | Logistic Models | 2 | 2014 | 1843 | 0.080 |
Why?
| | Heart Valve Diseases | 1 | 2011 | 161 | 0.080 |
Why?
| | Patient Discharge | 1 | 2015 | 768 | 0.080 |
Why?
| | Reference Values | 2 | 2010 | 741 | 0.080 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2011 | 175 | 0.080 |
Why?
| | Age Factors | 2 | 2018 | 2889 | 0.080 |
Why?
| | Pharmacogenetics | 1 | 2009 | 149 | 0.080 |
Why?
| | Sensitivity and Specificity | 3 | 2008 | 1690 | 0.080 |
Why?
| | Office Visits | 1 | 2008 | 79 | 0.080 |
Why?
| | Severity of Illness Index | 3 | 2018 | 2537 | 0.080 |
Why?
| | Coronary Artery Disease | 1 | 2013 | 607 | 0.070 |
Why?
| | Comorbidity | 2 | 2017 | 1449 | 0.070 |
Why?
| | Blood Gas Analysis | 1 | 2007 | 72 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1080 | 0.070 |
Why?
| | Miniaturization | 1 | 2006 | 23 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 2 | 2018 | 2099 | 0.070 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2021 | 133 | 0.070 |
Why?
| | Pilot Projects | 2 | 2021 | 1370 | 0.070 |
Why?
| | Aged, 80 and over | 4 | 2018 | 6346 | 0.070 |
Why?
| | Professional Competence | 1 | 2006 | 82 | 0.070 |
Why?
| | Blood Pressure | 2 | 2017 | 1530 | 0.060 |
Why?
| | Waist-Hip Ratio | 1 | 2005 | 30 | 0.060 |
Why?
| | Pattern Recognition, Automated | 1 | 2006 | 67 | 0.060 |
Why?
| | Myocardial Contraction | 1 | 2007 | 312 | 0.060 |
Why?
| | Carotid Stenosis | 1 | 2006 | 79 | 0.060 |
Why?
| | Ultrasonography, Doppler | 1 | 2005 | 105 | 0.060 |
Why?
| | Lipoproteins | 1 | 2005 | 160 | 0.060 |
Why?
| | Confidence Intervals | 1 | 2005 | 309 | 0.060 |
Why?
| | Age Distribution | 1 | 2005 | 339 | 0.060 |
Why?
| | Sex Distribution | 1 | 2005 | 335 | 0.060 |
Why?
| | ROC Curve | 2 | 2018 | 445 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2006 | 222 | 0.060 |
Why?
| | Physician-Patient Relations | 1 | 2008 | 462 | 0.060 |
Why?
| | Adolescent | 5 | 2021 | 17806 | 0.060 |
Why?
| | Triglycerides | 1 | 2005 | 470 | 0.060 |
Why?
| | Sternotomy | 1 | 2023 | 18 | 0.060 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2016 | 172 | 0.050 |
Why?
| | Protamines | 1 | 2023 | 5 | 0.050 |
Why?
| | Linear Models | 1 | 2005 | 770 | 0.050 |
Why?
| | Diagnosis, Differential | 2 | 2020 | 1340 | 0.050 |
Why?
| | Survival Analysis | 2 | 2018 | 1218 | 0.050 |
Why?
| | Sex Factors | 2 | 2018 | 1717 | 0.050 |
Why?
| | Atherosclerosis | 1 | 2006 | 342 | 0.050 |
Why?
| | Databases, Factual | 2 | 2018 | 1126 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1435 | 0.050 |
Why?
| | Chlorides | 1 | 2022 | 127 | 0.050 |
Why?
| | Doxorubicin | 1 | 2023 | 286 | 0.050 |
Why?
| | Factor Xa Inhibitors | 1 | 2023 | 138 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 494 | 0.050 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2021 | 26 | 0.050 |
Why?
| | Bradycardia | 1 | 2021 | 48 | 0.050 |
Why?
| | Vagus Nerve | 1 | 2021 | 79 | 0.050 |
Why?
| | Rivaroxaban | 1 | 2023 | 211 | 0.050 |
Why?
| | Young Adult | 4 | 2021 | 10461 | 0.050 |
Why?
| | Warfarin | 1 | 2020 | 135 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2021 | 372 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 1 | 2008 | 1177 | 0.040 |
Why?
| | Antithrombins | 1 | 2020 | 49 | 0.040 |
Why?
| | Operative Time | 1 | 2020 | 106 | 0.040 |
Why?
| | Tricuspid Valve | 1 | 2019 | 25 | 0.040 |
Why?
| | Disease Progression | 2 | 2019 | 2384 | 0.040 |
Why?
| | Europe | 1 | 2020 | 336 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 277 | 0.040 |
Why?
| | Patient Participation | 1 | 2022 | 360 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 210 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2005 | 2381 | 0.040 |
Why?
| | Sus scrofa | 1 | 2018 | 45 | 0.040 |
Why?
| | Decision Trees | 1 | 2018 | 80 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 172 | 0.040 |
Why?
| | Hemorrhage | 1 | 2023 | 618 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 100 | 0.040 |
Why?
| | Body Mass Index | 1 | 2005 | 1958 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 94 | 0.040 |
Why?
| | Advisory Committees | 1 | 2019 | 208 | 0.040 |
Why?
| | Italy | 1 | 2017 | 92 | 0.040 |
Why?
| | Blood Glucose | 1 | 2005 | 1821 | 0.030 |
Why?
| | Prosthesis Fitting | 1 | 2016 | 13 | 0.030 |
Why?
| | Thermal Conductivity | 1 | 2016 | 5 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2016 | 3542 | 0.030 |
Why?
| | Decision Making | 1 | 2022 | 781 | 0.030 |
Why?
| | Biomarkers | 1 | 2005 | 3414 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 345 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 178 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 268 | 0.030 |
Why?
| | Hospitals, Low-Volume | 1 | 2015 | 22 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 39 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1319 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2012 | 3004 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 545 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1351 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 117 | 0.030 |
Why?
| | Friction | 1 | 2013 | 13 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2015 | 151 | 0.030 |
Why?
| | Health Care Costs | 1 | 2017 | 380 | 0.030 |
Why?
| | Czech Republic | 1 | 2013 | 3 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2017 | 776 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 667 | 0.030 |
Why?
| | Motion | 1 | 2013 | 90 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2356 | 0.030 |
Why?
| | Algorithms | 2 | 2012 | 1468 | 0.030 |
Why?
| | Surface Properties | 1 | 2013 | 387 | 0.030 |
Why?
| | Quality Improvement | 1 | 2019 | 951 | 0.020 |
Why?
| | Veins | 1 | 2012 | 55 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2014 | 1122 | 0.020 |
Why?
| | Angiography | 1 | 2011 | 174 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 222 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3349 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 2811 | 0.020 |
Why?
| | Coronary Angiography | 1 | 2012 | 304 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1226 | 0.020 |
Why?
| | Patient Readmission | 1 | 2014 | 608 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1630 | 0.020 |
Why?
| | Wisconsin | 1 | 2008 | 91 | 0.020 |
Why?
| | Physicians' Offices | 1 | 2006 | 16 | 0.020 |
Why?
| | Observer Variation | 1 | 2006 | 295 | 0.020 |
Why?
| | Image Enhancement | 1 | 2006 | 158 | 0.020 |
Why?
| | Motivation | 1 | 2008 | 494 | 0.010 |
Why?
| | Population Surveillance | 1 | 2006 | 392 | 0.010 |
Why?
| | Health Behavior | 1 | 2008 | 704 | 0.010 |
Why?
| | Child | 1 | 2021 | 18348 | 0.010 |
Why?
| | Family Practice | 1 | 2006 | 427 | 0.010 |
Why?
|
|
Tzou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|